Abatacept is linked to lower mortality and fewer hospitalizations than rituximab in patients with rheumatoid ...

Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

The risk of ILD was highest within the first 2 years after IBD diagnosis (aHR 2.14, 95% CI 1.51-3.05) but remained ...

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...

Public pigeon feeding in Hyderabad, though seen as kindness, can cause severe lung diseases. Experts warn that droppings and ...

Liquidia Q2 sales hit $8.84 million after Yutrepia launch; PH-ILD study shows stable tolerability and improved walking ...

YUTREPIA™ surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA’s ...

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according ...

Pulmonary rehabilitation using minimal equipment achieved roughly the same benefits as when done with treadmills and other ...

Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...

The plaintiff is a neurosurgeon at the University of Virginia. He sued the University of Physicians Group alleging that a UVA ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.